Pain View IV
Release Date: October 29, 2010
Expiration Date: October 29, 2011
Expected time to complete this activity as designed: 90 minutes
This Pain View series will discuss two very important topics concerning the skyrocketing rates of prescription drug abuse in the United States. The first session of the 2-part series will discuss the current rise in prescription drug abuse in the United States. In Part 2, Dr. Fine will lead a discussion which will combat this, including the War on Drugs and REMS for Opioids.
Please remember to complete both parts 1 and 2 to receive 1.5 hours of continuing education credit.
This activity is designed for physicians, pharmacists, physician assistants, nurses, and other health care professionals who have an interest in enhancing their clinical skills in pain management.
Upon completion of this entire educational activity, participants should be able to:
- Understand the neurochemical mechanisms of drug addiction.
- Systematically examine the relative reinforcing effects of commonly abused medications.
- Evaluate the reasons for skyrocketing prescription drug abuse rates.
- Understand how to identify "at risk" patients within your practice and know what actions to take to structure and optimize opioid treatment and manage aberrant drug-related behavior.
- Understand the current regulatory and legal climate concerning prescription of opioid drugs.
- Review the impact of the War on Drugs on current crime and drug abuse issues.
- Examine the impact of American drug control policy on health care, including the Drug Enforcement Administration's impact on opioid use.
- Understand the broad constructs of risk minimization and the recent regulatory risk management initiative REMS in the United States.
This activity is eligible for credit through October 29, 2011. After this date, this activity will expire and no further credit will be awarded. There are no fees for participating in or receiving credit for this online educational activity.
Follow these steps to earn CME/CE credit:
- Read the target audience, learning objectives, and author disclosures.
- Complete a short pre-test before accessing the educational content.
- Complete the educational content online as designed or printed out.
- Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score of 70% on the test and complete the Activity Evaluation to provide feedback for future programming.
Certificates may be printed immediately after successfully completing the online self-assessment post-activity and evaluation.
Perry G. Fine, MD
Professor of Anesthesiology
Pain Research Center, School of Medicine
University of Utah
Salt Lake City, Utah
Dr. Perry Fine received his medical degree at the Medical College of Virginia in Richmond. He served an internship at Community Hospital of Sonoma County in Santa Rosa, California, and completed a residency at the University of Utah Health Sciences Center in Salt Lake City. Dr. Fine then completed a fellowship at the Smythe Pain Clinic of the University of Toronto in Ontario, Canada. He is currently professor of anesthesiology in the Pain Research Center of the School of Medicine at the University of Utah where he is an attending physician in the Pain Management Center.
Dr. Fine serves on the Board of Directors of the American Academy of Pain Medicine, the Society for Arts in Healthcare, and the American Pain Foundation. He also serves as the External Strategic Advisor for Capital Hospice in Washington, DC, and he is a consultant to the Center for Advanced Illness Coordinated Care based in Albany, New York. A widely published author in the fields of pain management and end-of-life care, Dr. Fine serves on the editorial boards of several peer-reviewed medical journals. He is the recipient of the 2007 American Academy of Hospice and Palliative Medicine Distinguished Hospice Physician Award and the 2008 American Pain Society John and Emma Bonica Public Service Award.
Aaron M. Gilson, PhD, MSSW
Director, US Program
Pain & Policy Studies Group/WHO Collaborating Center
Carbone Comprehensive Cancer Center
University of Wisconsin-Madison
Dr. Aaron Gilson received a PhD in social welfare and an MS degree in social work from the University of Wisconsin in Madison where he had a dual concentration in social policy and in child maltreatment, with emphasis on prevention, theory, and survey research. He also received an MS degree in psychology from Villanova University in Pennsylvania. Dr. Gilson is director of the US Program at the Pain & Policy Studies Group (PPSG)/WHO Collaborating Center for Policy and Communications in Cancer Care, a division of the Paul P. Carbone Comprehensive Cancer Center at the University of Wisconsin School of Medicine and Public Health.
A member of the American Pain Society, the Liaison Committee on Pain and Addiction, the American Academy of Pain Medicine, and the American Society of Addiction Medicine, Dr. Gilson has published and presented about topics relevant to health care professionals and regulators both in the United States and abroad. His recent activities involve developing a methodology to evaluate and quantify federal and state controlled substances and health care practice policies. Dr. Gilson currently is examining the extent that prescription opioid analgesics are being diverted by pharmacy thefts, and working to promote a public health approach to prescription medication abuse by identifying the sources of diversion.
Mary Lynn McPherson, PharmD, BCPS, CPE
Professor and Vice Chair
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Dr. Mary Lynn McPherson received her doctor of pharmacy degree from the University of Maryland School of Pharmacy. She is professor and vice chair in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy, and the director of Pharmacotherapy Services at University Care Waxter in Baltimore. Dr. McPherson has maintained a practice in both hospice (local and national) and ambulatory care her entire career. She teaches extensively in the PharmD curriculum on pain management and end-of-life care, including didactic and experiential content, and she also developed one of the first and few palliative care pharmacy residencies in the US.
Dr. McPherson serves on the Board of Directors of the Hospice Network of Maryland and is Chairman of the Board of the American Society of Pain Educators. She is a fellow in the American Society of Health-Systems Pharmacists and the American Pharmacists Association. Dr. McPherson has received the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the Maryland Pharmacists Association Innovative Practice Award, and the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award, among others. She has written four books, and many book chapters and peer-reviewed articles on pain management, palliative care, and other topics.
Micke A. Brown, BSN, RN
Director of Communications
American Pain Foundation
Micke Brown received her bachelor of science in degree in nursing from the University of Florida, Gainesville, along with advanced credentials in acute pain management from Schumpert Medical Center, Shreveport, Louisiana. As the Communications Director for the American Pain Foundation (APF), a national nonprofit organization serving people affected by pain through education, support, and advocacy, Ms. Brown's role is to develop and guide communications services that include policy, media and public awareness programming for APF.
Ms. Brown has more than 30 years experience in nursing, with 15 years in the specialty of pain management. Her work as a pain management nurse and pain advocate has focused on caring for patients with pain, and providing health care professionals with pain management training. In addition to clinical practice, Ms. Brown has extensive experience in establishing hospital-based pain programs, health care professional training, performance improvement projects, and has addressed issues that surround untreated pain, including ethical challenges, end-of-life care, cultural disparities, and care of special populations. Ms. Brown has served on the Board of Directors of both the Maryland Pain Initiative (MPI) and the Hospice of Washington County (Maryland), and is past president of the American Society for Pain Management Nursing (ASPMN), a professional organization dedicated to promoting the advancement of optimal nursing care for people affected by pain.
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 1.5 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-10-259-H01-P. Knowledge-based CPE activity.
Accreditation Statement: MediCom Worldwide, Inc., 101 Washington Street, Morrisville, PA 19067 is approved by the California Board of Registered Nursing, Provider Number CEP11380. MediCom designates this CNE activity for 1.5 contact hours. Program Number: 10-259-249
For information on applicability and acceptance of continuing nursing education credit for this activity, please consult your professional licensing board.
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), ACPE and California Board of Nursing, MediCom Worldwide, Inc. requires that all program planners, faculty, and providers who are in a position to control the content of a CE activity are required to disclose any relevant financial relationships they may have or have had within the last 12 months with the commercial supporter or the manufacturer(s) of any commercial device(s) discussed in this educational activity. Accordingly the following disclosures were made.
The presenting faculty reported the following:
Dr. Perry Fine has received honoraria related to formal advisory activities from Ameritox, Ltd., Cephalon, Inc., King Pharmaceuticals, Inc., Meda Pharmaceuticals Inc., and Purdue Pharma L.P. He has received consultant fees from Cephalon and Johnson & Johnson Services, Inc.
Dr. Aaron Gilson has received honoraria related to formal advisory activities from Meda Pharmaceuticals Inc. He has received grant support related to research activities from King Pharmaceuticals, Inc., as well as an unrestricted educational grant from Purdue Pharma L.P.
Dr. Mary Lynn McPherson has disclosed that she has no significant relationships with the grantors or any other commercial company whose products and services may be related to her presentation.
Micke Brown has disclosed that she has no significant relationships with the grantor or any other commercial company whose products and services may be related to her presentation.
Planner and Provider Financial Disclosures
The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, executive director, Bronwyn Boyes, PharmD, director, and Alan Vogenberg, RPh, FASCP, clinical advisor have nothing to disclose.
Adam J. Carinci, MD was the clinical reviewer for this activity and has nothing to disclose.
Conflict of Interest Resolution
To resolve identified conflicts of interest, the educational content was fully peer reviewed by members of the MediCom Content Review Committee. The resulting certified activity was found to provide educational content that is current, evidence-based, and fair balanced.
Off-Label Disclosures/Investigational Disclosures
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Perry Fine, Aaron Gilson, Mary Lynn McPherson, and Micke Brown indicated that their presentations would not include the discussion of unlabeled uses of commercial products or investigational/unapproved products not yet approved by the FDA for any use in the United States.
MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, Windows® 7, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft® Silverlight™.
If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at email@example.com.
Provided by MediCom Worldwide, Inc.
This activity is supported by an independent educational grant from Cephalon, Inc.
©2010 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242
No portion of this material may be copied or duplicated without the expressed permission of MediCom.